LGMD1

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instance_of gptkb:muscular_dystrophy
gptkbp:affects proximal muscles
gptkbp:associated_with gptkb:medical_research
gptkb:healthcare_access
gptkb:guidelines
rehabilitation services
patient registries
research funding
awareness campaigns
insurance coverage
outcome measures
family history
long-term care
social challenges
muscle weakness
advocacy organizations
exercise intolerance
genetic counseling
respiratory issues
biobanks
assistive devices
patient support groups
research collaborations
multidisciplinary care
muscle wasting
scoliosis
quality of life issues
clinical trials participation
educational needs
joint contractures
gait abnormalities
cardiac issues
psychosocial impact
myalgia
falling episodes
gptkbp:breeding_range chromosome 15
gptkbp:caused_by genetic mutations
gptkbp:clinical_trial fatigue
muscle cramps
progressive weakness
onset in childhood
gptkbp:diagnosis genetic testing
gptkbp:first_described_by 1990s
gptkbp:gene_involved gptkb:calpain_3_gene
dystrophin gene
sarcoglycan genes
https://www.w3.org/2000/01/rdf-schema#label LGMD1
gptkbp:inherits_from autosomal recessive
gptkbp:prevalence rare
gptkbp:related_to gptkb:LGMD2
gptkbp:research_focus gptkb:gene_therapy
clinical trials
muscle regeneration
gptkbp:symptoms difficulty walking
difficulty climbing stairs
shoulder weakness
gptkbp:treatment physical therapy
supportive care
occupational therapy
gptkbp:bfsParent gptkb:muscular_dystrophy
gptkbp:bfsLayer 5